Axillary-subclavian venous thrombosis

Reviews in Cardiovascular Medicine

Volumn 3, Issue SUPPL. 2, 2002, Pages

  Meissner, Meissner H ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Axillary subclavian venous thrombosis; Thrombolysis; Upper extremity deep venous thrombosis

Indexed keywords

ANTICOAGULANT AGENT; FIBRINOLYTIC AGENT; HEPARIN; UROKINASE;

ANTICOAGULANT THERAPY; ARM; AXILLARY VEIN; CLINICAL FEATURE; CLINICAL TRIAL; COMORBIDITY; DECOMPRESSION SURGERY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; HUMAN; LUNG EMBOLISM; MORTALITY; PATIENT SELECTION; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PROGNOSIS; REVIEW; RISK FACTOR; SUBCLAVIAN VEIN; SYMPTOMATOLOGY; THORAX SURGERY; VEIN CATHETERIZATION; VEIN MALFORMATION; VEIN THROMBOSIS;

EID: 0036994408     PISSN: 15306550     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (29)

1. Demeter SL, Pritchard JS, Piedad OH, et al. Upper extremity thrombosis: etiology and prognosis. Angiology. 1982;33:743-755.
2. Tilney NL, Griffiths HJG, Edwards EA. Natural history of major venous thrombosis of the upper extremity. Arch Surg. 1970;101:792-796.
3. Linblad B, Tengborn L, Bergvist D. Deep vein thrombosis of the axillary-subclavian veins: epidemiologic data, effects of different types of treatment, and late sequelae. Eur J Vasc Surg. 1988;2:161-165.
4. Horattas MC, Wright DJ, Fenton AH, et al. Changing concepts of deep venous thrombosis of the upper extremity: report of a series and review of the literature. Surgery. 1988;104:561-567.
5. Prescott SM, Tikoff G. Deep venous thrombosis of the upper extremity: a reappraisal. Circulation. 1979;59:350-355.
6. Painter TD, Karpf M. Deep venous thrombosis of the upper extremity: five years experience at a university hospital. Angiology. 1984;35:743-749.
7. AbuRahma AF, Sadler D, Stuart P, et al. Conventional versus thrombolytic therapy in spontaneous (effort) axillary-subclavian vein thrombosis. Am J Surg. 1991;161:459-465.
8. Urschel HC, Razzuk MA. Improved management of the Paget-Schroetter syndrome secondary to thoracic outlet compression. Ann Thorac Surg. 1991;52:1217-1221.
9. Heron E, Lozinguez O, Alhenc-Gelas M, et al. Hypercoagulable states in primary upper-extremity deep vein thrombosis. Arch Intern Med. 2000;160:382-386.
10. Hingorani A, Ascher E, Lorenson E, et al. Upper extremity deep venous thrombosis and its impact on morbidity and mortality rates in a hospital-based population. J Vasc Surg. 1997;26:853-860.
11. Grassi CJ, Bettman MA. Effort thrombosis: role of interventional therapy. Cardiovasc Intervent Radiol. 1990;13:317-322.
12. Hingorani A, Ascher E, Hanson J, et al. Upper extremity versus lower extremity deep venous thrombosis. Am J Surg. 1997;174:214-217.
13. Rutherford RB. Primary subclavian-axillary vein thrombosis: the relative roles of thrombolysis, percutaneous angioplasty, stents, and surgery. Semin Vasc Surg. 1998;11:91-95.
14. Wilson JJ, Zahn CA, Newman H. Fibrinolytic therapy for idiopathic subclavian-axillary vein thrombosis. Am J Surg. 1990;159:208-211.
15. Molina JE. Surgery for effort thrombosis of the subclavian vein. J Thorac Cardiovasc Surg. 1992;103:341-346.
16. Azakie A, McElhinney DB, Thompson RW, et al. Surgical management of subclavian-vein effort thrombosis as a result of thoracic outlet compression. J Vasc Surg. 1998;28:777-786.
17. Machleder HI. Evaluation of a new treatment strategy for Paget-Schroetter syndrome: spontaneous thrombosis of the axillary-subclavian vein. J Vasc Surg. 1993;17:305-315.
18. Monreal M, Lafoz E, Ruiz J, et al. Upper-extremity deep venous thrombosis and pulmonary embolism. A prospective study. Chest. 1991;99:280-283.
19. Monreal M, Raventos A, Lerma R, et al. Pulmonary embolism in patients with upper extremity DVT associated to venous central lines: a prospective study. Thromb Haemost. 1994;72:548-550.
20. Prandoni P, Polistena P, Cogo A, et al. Upper-extremity deep vein thrombosis. Risk factors, diagnosis, and complications. Arch Intern Med. 1997;157:57-62.
21. Donayre CE, White GH, Mehringer SM, et al. Pathogenesis determines late morbidity of axillosubclavian vein thrombosis. Am J Surg. 1986;152:179-184.
22. Campbell CB, Chandler JG, Tegtmeyer CJ, et al. Axillary, subclavian, and brachiocephalic obstruction. Surgery. 1977;82:816-826.
23. Heron E, Lozinguez O, Emmerich J, et al. Long-term sequelae of spontaneous axillary-subclavian venous thrombosis. Ann Intern Med. 1999;131:510-513.
24. Becker DM, Philbrick JT, Walker FB. Axillary and subclavian venous thrombosis. Prognosis and treatment. Arch Intern Med. 1991;151:1934-1943.
25. Hurlbert SN, Rutherford RB. Primary subclavian-axillary vein thrombosis. Ann Vasc Surg. 1995;9:217-223.
26. Beygui RE, Olcott C, Dalman RL. Subclavian vein thrombosis: outcome analysis based on etiology and modality of treatment. Ann Vasc Surg. 1997;11:247-255.
27. Lee MC, Grassi CJ, Belkin M, et al. Early operative intervention after thrombolytic therapy for primary subclavian vein thrombosis: an effective treatment approach. J Vasc Surg. 1998;27:1101-1108.
28. Kunkel JM, Machleder HI. Treatment of Paget-Schroetter syndrome. A staged, multidisciplinary approach. Arch Surg. 1989;124:1153-1158.
29. Meier GH, Pollak JS, Rosenblatt M, et al. Initial experience with venous stents in exertional axillary-subclavian vein thrombosis. J Vasc Surg. 1996;24:974-983.